ArticleTherapeutic advances in respiratory disease

Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials.

Sanjay Sethi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.